Diroximel Fumarate
CAS 1577222-14-0
Overview
Diroximel fumarate, sold under the brand name Vumerity, is a medication used for the treatment of relapsing forms of multiple sclerosis. It acts as an immunosuppressant and anti-inflammatory drug. Its most common adverse effects are flushing and gastrointestinal problems
Anant Labs manufacture and furnish high quality Diroximel Fumarate impurities for global markets. Our Diroximel Fumarate EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Technical Data
New Cat. No.ANTPRD5716
Old Cat. No.ANT-DRX-00
CAS1577222-14-0
Mol. FormulaC11H13NO6
Mol. Weight255.23 g/mol
IUPAC4-O-[2-(2,5-dioxopyrrolidin-1-yl)ethyl] 1-O-methyl (E)-but-2-enedioate
SMILESCOC(=O)/C=C/C(=O)OCCN1C(=O)CCC1=O
InChIInChI=1S/C11H13NO6/c1-17-10(15)4-5-11(16)18-7-6-12-8(13)2-3-9(12)14/h4-5H,2-3,6-7H2,1H3/b5-4+
InChI KeyYIMYDTCOUQIDMT-SNAWJCMRSA-N
Synonyms
1-[2-(2,5-Dioxo-1-pyrrolidinyl)ethyl] 4-methyl (2E)-2-butenedioateDiroximel fumarate1577222-14-0VumerityALKS-8700ALKS8700RDC-5108BIIB0984-O-[2-(2,5-dioxopyrrolidin-1-yl)ethyl] 1-O-methyl (E)-but-2-enedioateALKS 8700


